3Lemancewicz D, Dziecioi J, Piszcz J, et al. Influence of thalidomide on megakaryocytes in multiple myeloma [J]. Rooz Akad Med Bialymst, 2004,49 ( Supp 1 ) : 244 - 246.
4张之楠．血液病诊断及疗效标准[S]．第2版．北京：科学出版社，1998．373—380．
5Durie B G, Salmon S E. A clinical staging system for multiple myeloma[J]. Cancer, 1975,36 ( 3 ) : 842 - 854.
6Anagnostopoulos A, Weber D, Rankin K,et al. Thalidomide and dexamethasone for resistant multiple myeloma[J]. Br J Haematol,2003,121(5):768 -771.
7Owen O G. Trials investigate firest-line Thalidomide in multiple myeloma[J]. Lancet Oncol,2005,6(1) : 6 -9.
8Patrizia T, Elena Z, Claudia C,et al. Salvage the ray with thalidomide in patients with advanced relapsed/refractory multiple [ J ].Haematologica,2002,87 (4) : 408 - 414.
9Kyle R A, Rajkumar S V. Therapeutic application of thalidomide in multiple myeloma [ J ]. Semin Oncol, 2001,28 ( 6 ) : 583 - 587.
10Stewart A K, Chen C I, Howson-Jan K,et al. Results of a multicenter randomized phase Ⅱ trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant[J]. Clin Cancer Res,2004,10(24) : 8170 -8176.
5Davies FE, Raje N, Hideshima T, et al. Thalidomide and immunomodulatory dervatives augment natural killer cell cytotoxicity in multiple myeloma. Blood ,2001,98:210.
6Barlogie B, Desikan R, Eddlemon P, et al. Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide:identi- fication of prognostic factors in a phase 2 study of 169 patients. Blood, 2001,98:492.
7Hideshima T, Chauhan D, Shima Y, et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood ,2001,96:2943.
8Singhal S, Mehta J, Desikan R, et al. Antitumoract activity of thalidomide in refractory multiple myeloma. N Engl J Med, 1999,341:1565-1571.
9Yeh HS, Berenson JR. Myeloma bone disease and treatment options [J]. Eur J Cancer,2006,42(11 ) :1554 - 1563.
10Mundy GR, Raisz LG, Cooper RA, et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma[ J]. N Engl J Med, 1974, 291 (20) :1041 - 1046.
